These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39029904)

  • 1. Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma.
    Kwak Y; Nam SK; Park Y; Suh YS; Ahn SH; Kong SH; Park DJ; Lee HJ; Kim HH; Yang HK; Lee HS
    Mod Pathol; 2024 Oct; 37(10):100568. PubMed ID: 39029904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
    J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
    Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
    Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins.
    Qiu MZ; Chen Q; Zheng DY; Zhao Q; Wu QN; Zhou ZW; Yang LQ; Luo QY; Sun YT; Lai MY; Yuan SS; Wang FH; Luo HY; Wang F; Li YH; Zhang HZ; Xu RH
    Cell Rep; 2023 Jun; 42(6):112576. PubMed ID: 37285266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
    Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
    Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases].
    Gao R; Chen XY; Jin L
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
    Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
    Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
    Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
    World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
    van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
    Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine liver metastasis in gastric mixed adenoneuroendocrine carcinoma with trilineage cell differentiation: a case report.
    Zhang W; Xiao W; Ma H; Sun M; Chen H; Zheng S
    Int J Clin Exp Pathol; 2014; 7(9):6333-8. PubMed ID: 25337287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
    Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
    Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of gastric neuroendocrine carcinomas.
    Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
    Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
    Chen J; Wang A; Ji K; Bu Z; Ji J
    BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
    Ma F; Wang B; Xue L; Kang W; Li Y; Li W; Liu H; Ma S; Tian Y
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):2135-2142. PubMed ID: 32306127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia.
    Yamauchi H; Sakurai S; Nakazawa N; Yoshida T; Tabe Y; Saitoh K; Fukasawa T; Kiriyama S; Naitoh H; Kuwano H
    Int Surg; 2015 Mar; 100(3):562-7. PubMed ID: 25785345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes.
    Sinha N; Gaston D; Manders D; Goudie M; Matsuoka M; Xie T; Huang WY
    Hum Pathol; 2018 Mar; 73():16-25. PubMed ID: 28899736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Dulskas A; Pilvelis A
    Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation.
    Hashimoto R; Matsusaka K; Matsumura T; Hayano K; Kato N; Matsubara H; Ikeda JI
    Pathol Int; 2023 Jun; 73(6):261-263. PubMed ID: 37067391
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastric mixed adeno-neuroendocrine carcinoma with a large cell neuroendocrine component A case reports.
    Sert OZ; Gulmez S; Uzun O; Bozkurt H; Gunes OH
    Ann Ital Chir; 2019 Nov; 8():. PubMed ID: 31790369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.